3-Butylpentane-2,4-dione → 2-[4-(4-Butyl-3,5-dimethyl-1H-pyrazol-1-yl)phenyl]ethanol
반응식
Cl.[NH:2]([C:4]1[CH:9]=[CH:8][C:7]([CH2:10][CH2:11][OH:12])=[CH:6][CH:5]=1)[NH2:3].[CH2:13]([CH:17]([C:21](=O)[CH3:22])[C:18](=O)[CH3:19])[CH2:14][CH2:15][CH3:16]>>[CH2:13]([C:17]1[C:18]([CH3:19])=[N:3][N:2]([C:4]2[CH:5]=[CH:6][C:7]([CH2:10][CH2:11][OH:12])=[CH:8][CH:9]=2)[C:21]=1[CH3:22])[CH2:14][CH2:15][CH3:16]참가 물질
3
실험 절차
The title compound was prepared according to the procedure described in step 1 of Example 1 from 2-(4-hydrazinophenyl)ethanol hydrochloride and 3-n-butyl-2,4-pentanedione: MS (ESI) m/z 273 [M+H]+, 1H-NMR (CDCl3) δ 7.37-7.26 (4H, m), 3.87 (2H, t, J=6.8 Hz), 2.91 (2H, t, J=6.6 Hz), 2.39 (2H, t, J=7.6 Hz), 2.25 (3H, s), 2.22 (3H, s), 1.53-1.26 (4H, m), 0.94 (3H, t, J=7.1 Hz).
출처 및 근거
- ORD 기록
- ord-032491315a414c72abced4deddc4955c
- 출처 데이터셋
- uspto-grants-2006_02
- 특허 번호
- US07001917B2
반응 노트
불러오는 중…